LC
CELG

Landaas & Company’s Celgene Corp CELG Stock Holding History

Landaas & Company’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-630
Closed -$50K – 352
2018
Q2 		$50K Buy
+630
New +$52.3K 0.04% 152
2018
Q1 		– Sell
-630
Closed -$66K – 357
2017
Q4 		$66K Hold
630
– – 0.06% 121
2017
Q3 		$92K Buy
+630
New +$85.8K 0.08% 99

Other funds holding CELG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Landaas & Company's CELG Position: Q3 2018 in Review

Landaas & Company sold out of Celgene Corp (CELG) in Q3 2018, closing a stake of 630 shares — an estimated $50K sold.

Landaas & Company first reported a position in CELG in Q3 2017 and held it in 3 quarters. The position peaked at $92K in Q3 2017. 1,364 funds tracked by Wall St. Rank hold CELG as of Q3 2018.

  • Landaas & Company reported no remaining Celgene Corp position as of Q3 2018 after selling out during the quarter.
  • Landaas & Company sold 630 Celgene Corp shares in Q3 2018, an estimated $50K.
  • Landaas & Company first reported a position in Celgene Corp in Q3 2017 and held it in 3 quarters.
  • Landaas & Company's Celgene Corp position peaked at $92K in Q3 2017.
  • 1,364 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2018.

Based on Landaas & Company's 13F filing for Q3 2018, filed 14 Nov 2018.